Completed
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
Type of Sarcoma:
Advanced or Metastatic Untreated Soft Tissue Sarcoma
Drug:
Trabectedin Infused to Doxorubicin
Accrual Status:
Terminated
Overall Study Principal Investigator:
James E. Butrynski, MD
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute